Pharma

Your Unread Messages

See All

Your Article Summary

See Latest Articles

Novartis biological drug Ilaris approved in EU to treat children and adults with CAPS, a rare debilitating auto-inflammatory disease
Novartis, 10/29/09

The new biological medicine Ilaris has been approved in the European Union to treat adults and children as young as four years old with cryopyrin–associated periodic syndrome, a rare life–long auto–inflammatory disease with debilitating symptoms and few treatment options.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

U.S. Food and Drug Administration Approves ABILIFY for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients
Bristol Myers-Squibb Company, 11/24/09

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex Fully Covered Esophageal Stent
Boston Scientific, 11/24/09

AstraZeneca submits US New Drug Application for ticagrelor, an investigational antiplatelet agent
AstraZeneca, 11/23/09

 See all of Drug/Product Approvals

Today in Medical Devices/Products...keeping you current

Receive free subspecialty "5-minute updates" via email

Innovative polyurethane spray systems for district cooling
BayNews International, 11/24/09

New Makrofol ID film system developed - Watermarks for polycarbonate cards
BayNews International, 11/23/09

Baytubes carbon nanotubes in marine coatings help reduce frictional resistance
BayNews International, 11/23/09

 See all of Medical Devices/Products